Applied DNA Sciences Q2 EPS $(5.31) Misses $(4.50) Estimate, Sales $929.63K Miss $950.00K Estimate
Applied DNA Sciences Q2 EPS $(5.31) Misses $(4.50) Estimate, Sales $929.63K Miss $950.00K Estimate
應用DNA科學第二季度每股收益（5.31）未達到預期（4.50）美元，銷售額爲929.63萬美元，未達到950.00萬美元的預期
Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(5.31) per share which missed the analyst consensus estimate of $(4.50) by 18 percent. This is a 2555 percent decrease over losses of $(0.20) per share from the same period last year. The company reported quarterly sales of $929.63 thousand which missed the analyst consensus estimate of $950.00 thousand by 2.14 percent. This is a 78.91 percent decrease over sales of $4.41 million the same period last year.
應用DNA Sciences（納斯達克股票代碼：APDN）公佈的季度虧損爲每股5.31美元，比分析師普遍預期的4.50美元（4.50美元）低18％。這比去年同期每股虧損0.20美元（0.20美元）下降了2555％。該公司公佈的季度銷售額爲929,630美元，比分析師普遍預期的95萬美元低2.14％。這比去年同期的441萬美元銷售額下降了78.91％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。